19th Jul 2010 10:46
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES |
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: |
SkyePharma PLC |
|||||||||||||
2 Reason for the notification (please tick the appropriate box or boxes): |
||||||||||||||
An acquisition or disposal of voting rights |
Yes |
|||||||||||||
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached |
|
|||||||||||||
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments |
|
|||||||||||||
An event changing the breakdown of voting rights |
|
|||||||||||||
Other (please specify): |
|
|
||||||||||||
3. Full name of person(s) subject to the notification obligation:
|
UBS Investment Bank |
|||||||||||||
4. Full name of shareholder(s) (if different from 3.):
|
UBS AG London Branch |
|||||||||||||
5. Date of the transaction and date on which the threshold is crossed or reached:
|
14 July 2010 |
|||||||||||||
6. Date on which issuer notified:
|
16 July 2010 |
|||||||||||||
7. Threshold(s) that is/are crossed or reached:
|
6% |
|||||||||||||
8. Notified details: |
||||||||||||||
A: Voting rights attached to shares
|
||||||||||||||
Class/type of shares if possible using the ISIN CODE |
Situation previous to the triggering transaction |
Resulting situation after the triggering transaction |
||||||||||||
Number of Shares |
Number of Voting Rights |
Number of shares |
Number of voting rights |
% of voting rights |
||||||||||
Direct |
Direct |
Indirect |
Direct |
Indirect |
||||||||||
Ord Shares of £1 each |
1,452,702 |
1,452,702 |
1,349,505 |
1,349,505 |
- |
5.64% |
- |
|||||||
GB00B3BFNB64 |
||||||||||||||
B: Qualifying Financial Instruments |
||||||||||||||
Resulting situation after the triggering transaction
|
||||||||||||||
Type of financial instrument |
Expiration date |
Exercise/ Conversion Period |
Number of voting rights that may be acquired if the instrument is exercised/ converted.
|
% of voting rights |
||||||||||
|
|
|
|
|
||||||||||
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments |
||||||||||||||
Resulting situation after the triggering transaction
|
||||||||||||||
Type of financial instrument |
Exercise price |
Expiration date |
Exercise/ Conversion period |
Number of voting rights instrument refers to |
% of voting rights
|
|||||||||
|
|
|
|
|
Nominal |
Delta
|
||||||||
|
|
|||||||||||||
Total (A+B+C)
|
||||||||||||||
Number of voting rights |
Percentage of voting rights |
|||||||||||||
1,349,505 |
5.64% |
|||||||||||||
9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: |
||||||||||||||
|
||||||||||||||
Proxy Voting:
|
||||||||||||||
10. Name of the proxy holder:
|
|
|||||||||||||
11. Number of voting rights proxy holder will cease to hold:
|
|
|||||||||||||
12. Date on which proxy holder will cease to hold voting rights:
|
|
|||||||||||||
13. Additional information:
|
|
|||||||||||||
14. Contact name:
|
J Murphy |
|||||||||||||
15. Contact telephone number:
|
020 7491 5139 |
|||||||||||||
Related Shares:
SKP.L